Try reading the posts you respond to.
I’m willing to accept the findings of one of the preeminent MD PhD epidemiologists on the planet.
1 Like
You said 40 patient trial and all 40 were declared cured. So are you saying that it was only 40 patients involved in the trial?
Dear God mad read what is written. “A 40 patient trial.”
Ancedotal…
It’s not a cure yet.
Perhaps you might read what you have posted. If there were only 40 patients involved then it is not a meaningful trial.
Not according to the people doing the trial or those cured. It was a closely monitored and peer reviewed trial.
1 Like
The medical and scientific world disagree but by all means continue pontificating. It’s entertaining.
1 Like
Absolutely hilarious.
However, Paterson stressed it is important to test the drugs methodically "to give patients “the absolute best treatment rather than just someone’s guesses or someone’s anecdotal experiences from a few people.”
From the Newsweek article posted above…
There have already been patients treated with these in Australia and there’s been successful outcomes but it hasn’t been done in a controlled or a comparative way," he said
A literal expert saying exactly what I said and not what you said. Stop spreading bad info
Maybe this drug will work…maybe it wont.it could kill people as well unless you do more testing.
Stop spreading bad info.
1 Like
The literal expert is the guy who did the carefully controlled peer reviewed study in France published Wednesday.
1 Like
This good news is now being pumped out by the MSM and already…I can see things calming down a tad. The MSM needs to get behind this…big time…and then watch the stock market react positively?
2 Likes
They’ve been giving it to soldiers for years. It’s all good.
2 Likes
“Some even call it” hydroxychloroquine is somewhat safer
There will still need to be quarantines/social distancing, but this could help those that contract the Chinese virus who would otherwise die without it.
1 Like
One study with 40 patients…which is a good start but far from a miracle treatment…which is what Dr. Fauci was saying.
One thing we have learned over the years of pharmaceutical research is subtle genetic differences lead to very different phenotypic responses.
There is no study that shows this will have broad-based efficacy yet.
1 Like
It’d be interesting to know the blood type of those involved in the trial. If predominantly A, we may have most of this licked.
Nobody is claiming otherwise and why I pointed out the fact it was a very small trial.
The study from France
If they were predominantly O it would suggest a much larger percentage of patients will likely be benefit.
Type A is more prevalent in Asia than the rest of the world if I remember right which would explain the disproportional representation if typoe A’'s being affected.
